Cell Culture Technology– category –
-
Cell Culture Technology Weekly Report October 11, 2026
▼ ▼ ▼ If the infographic makes you want to read the full report, please click the download button below. ▼ ▼ ▼ 📄 Weekly Report October 11, 2026 (PDF) — Download Weekly Report October 11, 2026 (PDF) — DownloadDownload 🎙 Podcast October 1... -
PackGene: Dyno AAV capsid ratio at 10L preclinical scale
PR Newswire China Overview PackGene Biotech announced successful client AAV manufacturing projects via the Dyno Frontiers Network, demonstrating reliable and scalable production across multiple Dyno® capsids. Utilizing its proprietary π-... -
Raman PAT: Automated glucose feeding and mAb titer specs
BioProcess Tools USA Overview Automated glucose feeding, coupled with Raman Process Analytical Technology (PAT) and feedback control, has achieved groundbreaking results in monoclonal antibody (mAb) manufacturing. This system demonstrabl... -
WuXiUP: WuXi Biologics AI bioprocess and 110x productivity
BioProcess International China Overview China's WuXi Biologics has rapidly industrialized biopharmaceutical manufacturing through cell line/process optimization, its WuXiUP continuous bioprocess technology, and AI integration. Notably, t... -
Xuri W25: GMP-compliant TIL manufacturing process explained
Frontiers Unknown Overview A study in Frontiers details a platform for manufacturing tumor-infiltrating lymphocytes (TILs) from various solid tumor types using a closed-system Xuri W25 Bioreactor for automated culture and perfusion. This... -
Sartorius Eveo: CAR-T manufacturing costs and 2026 specs
Onyx Newsroom Germany Overview Sartorius introduced its automated Eveo Cell Therapy Platform at the Cell & Gene Meeting on the Mesa, aiming to reduce autologous CAR-T batch costs to under $40,000 per patient and cut capital/operating... -
Continuous Bioprocessing: Perfusion culture efficiency explained
Raspa Pharma India Overview Recent advancements in bioprocess engineering, including continuous bioprocessing, intensified feeding strategies, and perfusion culture, are significantly boosting the efficiency and productivity of biopharma... -
NK Cell Therapy: Japan’s 2014 RMPA law and expedited approval path
Grand Green Osaka Umekita Clinic Japan Overview Japan's Regenerative Medical Products Act (RMPA), implemented in 2014, facilitates rapid approval for regenerative medicine products, including NK cell therapies, significantly broadening i... -
Perfusion Culture vs Fed-Batch: 2.45x carbon footprint reduction
BioProcess Tools USA Overview BioProcess Tools reports that perfusion bioreactor processes exhibit significantly lower carbon footprints per kilogram of product compared to fed-batch processes. This advantage stems primarily from perfusi... -
NouvSight001: iRegene Therapeutics FDA Phase 1/2 trial timeline
Retinal Physician USA Overview iRegene Therapeutics has received FDA clearance to initiate a Phase 1/2 clinical trial for NouvSight001, an allogeneic photoreceptor cell therapy targeting retinitis pigmentosa (RP). The therapy leverages i...
